| Click here for the Options IX Programme
Click here for the Options IX Programme + Abstracts (9307KB) |
|
Nancy Cox, PhD
Past Director of the Influenza Division at the Centers for Disease Control and Prevention (CDC) and Director of CDC's World Health Organization (WHO) Collaborating Center for Surveillance, Epidemiology and Control of influenza |
|
|||||||||||||
|
Public Health Plenary Session:
Addressing the Public Health Threat of Influenza: Recognition, Prevention and Treatment
Nahoko Shindo, MD, PhD
World Health Organisation, Geneva, Switzerland. Yuelong Shu, PhD
Chinese National Influenza Center, National Institute for Viral Disease, Control and Prevention, Beijing, China. Virology & Pathogenesis Plenary Session:
Molecular Studies for Vaccines and Antivirals
Stephen Cusack, PhD, FRS European Molecular Biology Laboratory, Grenoble Outstation, Grenoble, France. Peter Palese Icahn School of Medicine at Mount Sinai, New York, NY, USA. Yoshihiro Kawaoka, DVM, PhD University of Wisconsin-Madison/University of Tokyo, Madison, WI, USA Clinical Science Plenary Session:
Newer Therapies for Influenza: Hurdles and ProgressMenno de Jong, MD, PhD University of Amsterdam, Amsterdam, The Netherlands. Novel Antiviral Agents in Advanced Development (not available)
Frederick Hayden, MD University of Virginia School of Medicine, Charlottesville, VA, USA. Combination Antivirals and Antibody-Based Therapies John Beigel, MDLeidos/NIAID, Bethsheda, MD, USA. Closing Plenary Session: The Future Threats from Influenza
Influenza at the Animal-Human Interface
David Swayne, DVM, PhD National Poultry Research Center - USDA, Athens, GA, USA. Forecasting the Future of Flu Trevor Bedford, PhD Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Improving on Influenza Vaccines: Managing the Challenges of Vaccine Mismatch Dan Jernigan, MD, MPH US Centers for Disease Control and Prevention, Atlanta, GA, USA. Recap Video
|
